trending Market Intelligence /marketintelligence/en/news-insights/trending/403jb6ihzvlfk35pr1lqta2 content esgSubNav
In This List

Synthetic Biologics appoints interim CEO to permanent role

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Synthetic Biologics appoints interim CEO to permanent role

Synthetic Biologics Inc. said it named Steven Shallcross CEO.

Shallcross, who had been serving as interim CEO, will also continue as the company's CFO. He was also appointed as a director of the company.

Rockville, Md.-based Synthetic Biologics develops therapeutics designed to preserve the human microbiome.